{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:44:35Z","timestamp":1792928675114,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117292","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:11:12Z","timestamp":1737198672000},"page":"117292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Artesunate\u2014multiple pharmacological effects beyond treating malaria"],"prefix":"10.1016","volume":"286","author":[{"given":"Yuzhi","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-1734","authenticated-orcid":false,"given":"Hui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117292_bib1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.pt.2019.09.005","article-title":"Artemisinin bioactivity and resistance in malaria parasites","volume":"35","author":"Talman","year":"2019","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ejmech.2025.117292_bib2","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-A gift from traditional Chinese medicine to the world (nobel lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117292_bib3","doi-asserted-by":"crossref","first-page":"117032","DOI":"10.1016\/j.ejmech.2024.117032","article-title":"Novel frontiers through nitrogen substitution at 6th, 10th and 11th position of artemisinin: synthetic approaches and antimalarial activity","volume":"281","author":"Yadav","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117292_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pt.2015.10.010","article-title":"A brief history of qinghaosu","volume":"31","author":"White","year":"2015","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ejmech.2025.117292_bib5","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117292_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cell.2014.07.011","article-title":"Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate","volume":"158","author":"Lisewski","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117292_bib7","series-title":"WHO Global Malaria Programme","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117292_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/pharmaceutics14030504","article-title":"Recent advances in the therapeutic efficacy of artesunate","volume":"14","author":"Ruwizhi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117292_bib9","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"T. Oesch, The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117292_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.apsb.2020.09.001","article-title":"Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics","volume":"11","author":"Dolivo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117292_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104901","article-title":"T. Tran, Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","volume":"158","author":"Cheong","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib12","doi-asserted-by":"crossref","first-page":"154259","DOI":"10.1016\/j.phymed.2022.154259","article-title":"Artesunate: a review of its therapeutic insights in respiratory diseases","volume":"104","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib13","doi-asserted-by":"crossref","first-page":"1097206","DOI":"10.3389\/fphar.2023.1097206","article-title":"Therapeutic potential of artemisinin and its derivatives in managing kidney diseases","volume":"14","author":"Jin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib14","author":"Malaria report 2024","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117292_bib15","series-title":"Guidelines for the Treatment of Malaria","year":"2015"},{"key":"10.1016\/j.ejmech.2025.117292_bib16","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1093\/cid\/ciac728","article-title":"Food and drug administration approval of artesunate for severe malaria: enough to achieve best practice?","volume":"76","author":"Thomas","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2471\/BLT.19.231506","article-title":"van der Weije, Use of rectal artesunate for severe malaria at the community level, Zambia","volume":"97","author":"Green","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ejmech.2025.117292_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2021.04.020","article-title":"Intranasal artesunate-loaded nanostructured lipid carriers: a convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria","volume":"334","author":"Agbo","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2025.117292_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpddr.2021.05.008","article-title":"Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria","volume":"16","author":"Zech","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ejmech.2025.117292_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciz206","article-title":"Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France","volume":"70","author":"El Ket","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib21","first-page":"CD006404","article-title":"Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria","volume":"6","author":"Pryce","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2025.117292_bib22","first-page":"e02242","article-title":"Efficacy and safety of pyronaridine-artesunate plus single-dose primaquine for treatment of uncomplicated Plasmodium falciparum malaria in eastern Cambodia","volume":"63","author":"Leang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117292_bib23","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/cid\/ciz580","article-title":"Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017-2018)","volume":"70","author":"Quang Bui","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/cid\/ciab425","article-title":"Efficacy, safety and tolerability of pyronaridine-artesunate in asymptomatic malaria-infected individuals: a randomized controlled trial","volume":"74","author":"Dabira","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib25","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117292_bib26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3201\/eid2608.191547","article-title":"Increased sensitivity of Plasmodium falciparum to artesunate\/amodiaquine despite 14 Years as first-line malaria treatment, Zanzibar","volume":"26","author":"Msellem","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111311","article-title":"4-chloro eugenol interacts synergistically with artesunate against drug resistant P. falciparum inducing oxidative stress","volume":"137","author":"Mina","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117292_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2019.03.031","article-title":"Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria","volume":"562","author":"Ismail","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.117292_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117292_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"White","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2025.117292_bib31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117292_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/cid\/ciaa628","article-title":"Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia","volume":"73","author":"Mairet-Khedim","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biomaterials.2018.02.026","article-title":"Liposomes of dimeric artesunate phospholipid: a combination of dimerization and self-assembly to combat malaria","volume":"163","author":"Ismail","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2025.117292_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ebiom.2019.06.026","article-title":"Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite","volume":"45","author":"Kannan","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Tracking Resistance to Artemisinin Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117292_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pt.2020.09.011","article-title":"Triple artemisinin-based combination therapies for malaria - a new paradigm?","volume":"37","author":"van der Pluijm","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2025.117292_bib37","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/S0140-6736(20)32400-4","article-title":"Triple artemisinin-based combination therapies for malaria: proceed with caution","volume":"396","author":"Wang","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117292_bib38","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMp1901233","article-title":"A temporizing solution to \u201cartemisinin resistance\"","volume":"380","author":"Wang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117292_bib39","first-page":"743","article-title":"Mechanistic investigation of the specific anticancer property of artemisinin and its combination with aminolevulinic acid for enhanced anticolorectal cancer activity, ACS Cent","volume":"3","author":"Wang","year":"2017","journal-title":"Sci"},{"key":"10.1016\/j.ejmech.2025.117292_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3892\/ol.2021.13011","article-title":"Progress on the study of the anticancer effects of artesunate","volume":"22","author":"Yang","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2025.117292_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13045-018-0561-0","article-title":"Artesunate shows potent anti-tumor activity in B-cell lymphoma","volume":"11","author":"Vatsveen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2025.117292_bib42","doi-asserted-by":"crossref","first-page":"110167","DOI":"10.1016\/j.cellsig.2021.110167","article-title":"Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling","volume":"88","author":"Chen","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.117292_bib43","doi-asserted-by":"crossref","first-page":"172953","DOI":"10.1016\/j.ejphar.2020.172953","article-title":"Evaluation of artesunate for the treatment of adult T-cell leukemia\/lymphoma","volume":"872","author":"Ishikawa","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib44","doi-asserted-by":"crossref","first-page":"26314","DOI":"10.1074\/jbc.M114.568253","article-title":"Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors","volume":"289","author":"Kobayashi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117292_bib45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jcmm.14717","article-title":"Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117292_bib46","doi-asserted-by":"crossref","first-page":"155274","DOI":"10.1016\/j.phymed.2023.155274","article-title":"Artesunate in glioblastoma therapy: case reports and review of clinical studies","volume":"123","author":"Strik","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib47","doi-asserted-by":"crossref","first-page":"113705","DOI":"10.1016\/j.biopha.2022.113705","article-title":"Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation","volume":"155","author":"Cao","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117292_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","article-title":"Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33\/2)","volume":"54","author":"von Hagens","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12951-022-01569-5","article-title":"Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy","volume":"20","author":"Gu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2025.117292_bib50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2019.12.035","article-title":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","volume":"157","author":"Trimble","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejmech.2025.117292_bib51","doi-asserted-by":"crossref","first-page":"615889","DOI":"10.3389\/fphar.2021.615889","article-title":"Artesunate regulates neurite outgrowth inhibitor protein B receptor to overcome resistance to sorafenib in hepatocellular carcinoma cells","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","article-title":"Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy","volume":"20","author":"Ma","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.117292_bib53","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41401-020-0395-5","article-title":"Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells","volume":"41","author":"Yao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117292_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117292_bib55","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s12276-022-00780-6","article-title":"Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117292_bib56","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ddr.21590","article-title":"Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer","volume":"80","author":"Kumar","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2025.117292_bib58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.ejmech.2025.117292_bib59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/cancers12040919","article-title":"Artesunate affects T antigen expression and survival of virus-positive Merkel cell carcinoma","volume":"12","author":"Sarma","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.117292_bib60","doi-asserted-by":"crossref","first-page":"714646","DOI":"10.3389\/fonc.2021.714646","article-title":"Artesunate suppresses choroidal melanoma vasculogenic mimicry formation and angiogenesis via the wnt\/CaMKII signaling Axis","volume":"11","author":"Geng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.117292_bib61","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/cells9122643","article-title":"Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction","volume":"9","author":"Zhao","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117292_bib62","doi-asserted-by":"crossref","first-page":"116730","DOI":"10.1016\/j.lfs.2019.116730","article-title":"Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K\/AKT pathway and downregulating HIF-1alpha expression","volume":"233","author":"Zhu","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.ejmech.2025.117292_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2016.07.002","article-title":"Immune suppressive properties of artemisinin family drugs","volume":"166","author":"Hou","year":"2016","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117292_bib64","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkr017","article-title":"Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC","volume":"66","author":"Li","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117292_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ja.2013.22","article-title":"Artesunate has its enhancement on antibacterial activity of \u03b2-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA)","volume":"66","author":"Jiang","year":"2013","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2025.117292_bib66","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.intimp.2011.02.028","article-title":"Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin","volume":"11","author":"Jiang","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2025.117292_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032424","article-title":"SM934 treated lupus-prone NZB \u00d7 NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development","volume":"7","author":"Hou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117292_bib68","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.phymed.2016.06.004","article-title":"Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines","volume":"23","author":"Jiang","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cns.12066","article-title":"Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe\/PS1dE9 transgenic mice via inhibition of nuclear factor-\u03baB and NLRP3 inflammasome activation","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.117292_bib70","doi-asserted-by":"crossref","first-page":"173020","DOI":"10.1016\/j.ejphar.2020.173020","article-title":"Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB\/c mice","volume":"874","author":"Bai","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib71","doi-asserted-by":"crossref","first-page":"105817","DOI":"10.1016\/j.intimp.2019.105817","article-title":"Artesunate alleviates imiquimod-induced psoriasis-like dermatitis in BALB\/c mice","volume":"75","author":"Huang","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2025.117292_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115309","article-title":"The interrupted cross-talk of inflammatory and oxidative stress trajectories signifies the effect of artesunate against hepatic ischemia\/reperfusion-induced inflammasomopathy","volume":"409","author":"Ghoneim","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41401-019-0289-6","article-title":"Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4\/TRAF6 and PLC\u03b31-Ca2+-NFATc1 signaling pathway","volume":"41","author":"Zeng","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117292_bib74","doi-asserted-by":"crossref","first-page":"111382","DOI":"10.1016\/j.biopha.2021.111382","article-title":"Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62\/Nrf2 signaling","volume":"137","author":"Su","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117292_bib75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-019-1935-6","article-title":"A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients","volume":"21","author":"Ma","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2025.117292_bib76","doi-asserted-by":"crossref","first-page":"153381","DOI":"10.1016\/j.phymed.2020.153381","article-title":"Artesunate inhibits Sjogren\u2019s syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-kappaB signaling","volume":"80","author":"Zhan","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0961203316651738","article-title":"Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus","volume":"26","author":"Feng","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.ejmech.2025.117292_bib78","doi-asserted-by":"crossref","first-page":"111462","DOI":"10.1016\/j.intimp.2023.111462","article-title":"Artesunate attenuates serum amyloid A-induced M1 macrophage differentiation through the promotion of PHGDH","volume":"127","author":"Lu","year":"2024","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2025.117292_bib79","doi-asserted-by":"crossref","first-page":"152965","DOI":"10.1016\/j.phymed.2019.152965","article-title":"Therapeutic effects of artesunate on lupus-prone MRL\/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway","volume":"62","author":"Dang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib80","doi-asserted-by":"crossref","first-page":"173630","DOI":"10.1016\/j.ejphar.2020.173630","article-title":"Artesunate protects immunosuppression mice induced by glucocorticoids via enhancing pro-inflammatory cytokines release and bacterial clearance","volume":"890","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib81","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1111\/bph.15158","article-title":"Artesunate interacts with the vitamin D receptor to reverse sepsis-induced immunosuppression in a mouse model via enhancing autophagy","volume":"177","author":"Shang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib82","doi-asserted-by":"crossref","first-page":"111234","DOI":"10.1016\/j.biopha.2021.111234","article-title":"Artesunate: a natural product-based immunomodulator involved in human complement","volume":"136","author":"Song","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117292_bib83","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2018.02.013","article-title":"Artesunate-derived monomeric, dimeric and trimeric experimental drugs - their unique mechanistic basis and pronounced antiherpesviral activity","volume":"152","author":"Hahn","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib84","doi-asserted-by":"crossref","first-page":"104700","DOI":"10.1016\/j.antiviral.2019.104700","article-title":"A highly potent trimeric derivative of artesunate shows promising treatment profiles in experimental models for congenital HCMV infection in vitro and ex vivo","volume":"175","author":"Jacquet","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib85","doi-asserted-by":"crossref","first-page":"104788","DOI":"10.1016\/j.antiviral.2020.104788","article-title":"The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: focus on prophylactic efficacy and oral treatment of immunocompetent mice","volume":"178","author":"Wild","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijid.2020.08.032","article-title":"Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: in vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate","volume":"99","author":"Gendrot","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib87","doi-asserted-by":"crossref","first-page":"101873","DOI":"10.1016\/j.tmaid.2020.101873","article-title":"Antimalarial drugs inhibit the replication of SARS-CoV-2: an in vitro evaluation","volume":"37","author":"Gendrot","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117292_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pt.2020.10.003","article-title":"Repurposing antimalarials to tackle the COVID-19 pandemic","volume":"37","author":"Krishna","year":"2021","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ejmech.2025.117292_bib89","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ph14100954","article-title":"A drug repurposing approach for antimalarials interfering with SARS-CoV-2 spike protein receptor binding domain (RBD) and human angiotensin-converting enzyme 2 (ACE2)","volume":"14","author":"Coghi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117292_bib90","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1080\/07391102.2020.1796809","article-title":"Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19","volume":"39","author":"Sehailia","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.117292_bib91","doi-asserted-by":"crossref","first-page":"680127","DOI":"10.3389\/fcimb.2021.680127","article-title":"Artemether, artesunate, arteannuin B, echinatin, licochalcone B and andrographolide effectively inhibit SARS-CoV-2 and related viruses in vitro","volume":"11","author":"Hu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117292_bib92","article-title":"P.H. Seeberger, In vitro efficacy of artemisinin-based treatments against SARS-CoV-2","volume":"11","author":"Zhou","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117292_bib93","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1016\/j.vaccine.2019.09.077","article-title":"Artesunate enhances the immune response of rabies vaccine as an adjuvant","volume":"37","author":"Luo","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2025.117292_bib94","doi-asserted-by":"crossref","first-page":"105635","DOI":"10.1016\/j.antiviral.2023.105635","article-title":"Artesunate inhibits PDE4 leading to intracellular cAMP accumulation, reduced ERK\/MAPK signaling, and blockade of influenza A virus vRNP nuclear export","volume":"215","author":"Yang","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib95","doi-asserted-by":"crossref","first-page":"104908","DOI":"10.1016\/j.antiviral.2020.104908","article-title":"Repurposing Pyramax\u00ae, quinacrine and tilorone as treatments for Ebola virus disease","volume":"182","author":"Lane","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib96","doi-asserted-by":"crossref","first-page":"1489050","DOI":"10.1155\/2016\/1489050","article-title":"The potential therapeutic effects of artesunate on stroke and other central nervous system diseases","volume":"2016","author":"Zuo","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2025.117292_bib97","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117292_bib98","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41368-023-00245-0","article-title":"Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development","volume":"15","author":"Liang","year":"2023","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.ejmech.2025.117292_bib99","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.04229-14","article-title":"Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms","volume":"59","author":"De Cremer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117292_bib100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11046-011-9445-3","article-title":"P.U. Sarma, Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin","volume":"172","author":"Gautam","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ejmech.2025.117292_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fmicb.2016.00743","article-title":"A drug combination screen identifies drugs active against amoxicillin-induced round bodies of in vitro Borrelia burgdorferi persisters from an FDA drug library","volume":"7","author":"Feng","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117292_bib102","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/mdr.2018.0463","article-title":"Synergistic activity of fluoroquinolones combining with artesunate against multidrug-resistant Escherichia coli","volume":"26","author":"Wei","year":"2020","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ejmech.2025.117292_bib103","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.3390\/ijms241311008","article-title":"Artesunate dry emulsion formulation combined with antibiotics for treatment of Helicobacter pylori infections: in Vitro\/in Vivo evaluation","volume":"24","author":"Le-Tien","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117292_bib104","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12931-021-01687-y","article-title":"Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-\u03b3\/TGF-\u03b21\/Smad2\/3 signalling pathway","volume":"22","author":"Pan","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2025.117292_bib105","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1096\/fj.201900146R","article-title":"Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells","volume":"33","author":"Li","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2025.117292_bib106","doi-asserted-by":"crossref","first-page":"155382","DOI":"10.1016\/j.phymed.2024.155382","article-title":"Artesunate improves glucose and lipid metabolism in db\/db mice by regulating the metabolic profile and the MAPK\/PI3K\/Akt signalling pathway","volume":"126","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117292_bib107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2018.07.011","article-title":"Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4\/NF-\u03baB\/NLRP3 inflammasome pathway","volume":"293","author":"Sun","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.117292_bib108","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway","volume":"109","author":"Kong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117292_bib109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2019.04.017","article-title":"Artesunate protects against surgery-induced knee arthrofibrosis by activating Beclin-1-mediated autophagy via inhibition of mTOR signaling","volume":"854","author":"Wan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2018.10.048","article-title":"Artesunate inhibits fibroblasts proliferation and reduces surgery-induced epidural fibrosis via the autophagy-mediated p53\/p21waf1\/cip1 pathway","volume":"842","author":"Wan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117292_bib111","doi-asserted-by":"crossref","first-page":"894963","DOI":"10.3389\/fphar.2022.894963","article-title":"Artesunate therapy alleviates fracture-associated chronic pain after orthopedic surgery by suppressing CCL21-dependent TREM2\/DAP12 inflammatory signaling in mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:07:15Z","timestamp":1740366435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":111,"alternative-id":["S0223523425000571"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117292","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate\u2014multiple pharmacological effects beyond treating malaria","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117292"}}